drugset / Trial / NCT00149253

Pre-Emptive Analgesia Efficacy of Etoricoxib for Postoperative Pain

NCT00149253

Phase 3 Completed 50 enrolled Khon Kaen University
RandomizedParallel-groupDouble-blindTreatment

Summary

Taken together, studies of the value of pre-emptive analgesia are inconclusive. This randomized, double-blind, dose-ranging, placebo-controlled study was therefore designed to test that a reduction in post-operative morphine consumption can be achieved by a single-dose of etoricoxib before induction of anesthesia.

Timeline

Start
2004-12
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoricoxib Small molecule 120 mg Oral
Subject Etoricoxib Small molecule 180 mg Oral

Indications

No indication recorded.